Author Correction: Ascorbic acid as an adjunctive therapy in critically ill patients with COVID-19: a propensity score matched study
Main Authors: | Khalid Al Sulaiman, Ohoud Aljuhani, Khalid Bin Saleh, Hisham A. Badreldin, Abdullah Al Harthi, Mohammed Alenazi, Aisha Alharbi, Rahmah Algarni, Shmeylan Al Harbi, Abdullah M. Alhammad, Ramesh Vishwakarma, Sarah Aldekhyl |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2021-09-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-021-99146-7 |
Similar Items
-
Ascorbic acid as an adjunctive therapy in critically ill patients with COVID-19: a propensity score matched study
by: Khalid Al Sulaiman, et al.
Published: (2021-09-01) -
Evaluation of thiamine as adjunctive therapy in COVID-19 critically ill patients: a two-center propensity score matched study
by: Khalid Al Sulaiman, et al.
Published: (2021-06-01) -
Clinical features and outcomes of critically ill patients with coronavirus disease 2019 (COVID-19): A multicenter cohort study
by: Khalid A. Al Sulaiman, et al.
Published: (2021-04-01) -
Designing, implementing and evaluating a teaching sequence about physical and chemical change for Saudi school students aged 15-16
by: Alhammad, Khalid Sulaiman
Published: (2013) -
Association between β-blocker use and mortality in critically ill patients: a nested cohort study
by: Shmeylan A. Al Harbi, et al.
Published: (2018-05-01)